Home Industry Reports Custom Research Blogs About Us Contact us

U.S. Preimplantation Genetic Testing Market

Report ID: FBI 5248

|

Published Date: Aug-2024

|

Format : PDF, Excel

The U.S. preimplantation genetic testing market is expected to see significant growth in the coming years due to the increasing demand for advanced genetic testing technologies in the field of Assisted Reproductive Technology (ART). The market is also driven by rising awareness among the population regarding the benefits of preimplantation genetic testing in preventing genetic disorders in offspring and improving pregnancy success rates.

Two key growth drivers for the U.S. preimplantation genetic testing market include advancements in genetic testing technologies, such as Next-Generation Sequencing (NGS) and Microarray, which allow for more accurate and comprehensive genetic analysis of embryos, and the growing prevalence of genetic disorders among couples, leading to increased demand for preimplantation genetic testing services.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
However, the market faces certain restraints, including high costs associated with preimplantation genetic testing procedures, which may limit access for certain segments of the population, and ethical concerns surrounding the use of genetic testing technologies to select embryos based on specific genetic traits.

In terms of segment analysis, the U.S. preimplantation genetic testing market can be divided into technology type (NGS, Microarray, others), test type (aneuploidy screening, single-gene disorder screening, chromosomal translocation screening, others), application (embryo testing, newborn screening, others), and end-user (fertility clinics, hospitals, research centers).

The competitive landscape of the U.S. preimplantation genetic testing market is characterized by the presence of several key players, such as Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., and CooperSurgical, Inc. These companies are investing in research and development activities to improve their product offerings and expand their market presence. Additionally, partnerships, collaborations, and strategic acquisitions are common strategies adopted by players in the market to enhance their competitive position.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Preimplantation Genetic Testing Market Size & Shar...

RD Code : 24